Toggle navigation
Solutions
Subscription
Media Tours
Multichannel News Releases
Media Placements
Podcasts
Creative
Webcast Services
Guaranteed Paid Placement
MultiVu Dashboard
Social Video
Blog
Resources
Success Stories
Webinars
News
About
Contact Us
×
Solutions
Subscription
Media Tours
Multichannel News Releases
Media Placements
Podcasts
Creative
Webcast Services
Guaranteed Paid Placement
MultiVu Dashboard
Social Video
Blog
Resources
Success Stories
Webinars
News
About
Contact Us
News
AbbVie (NYSE: ABBV) today announced that RINVOQ® (upadacitinib) is indicated in the U.S. for the treatment of pediatric patients two years of age and older....
Connect with us:
Get Started!
Connect with us: